Running summarizing tools on a new article
Check the paper below, then start its synthesis.
Palmitic acid promotes glomerulosclerosis via TGF-β1 upregulation in podocytes
A. k. Pasupulati
Abstract: Podocytes are terminally differentiated visceral epithelial cells of the glomerulus and play a vital role in renal filtration. Nevertheless, they are vulnerable to several insults in obesity and metabolic syndrome. Obesity-related glomerulopathy (ORG) is characterized by podocyte hypertrophy, reduced podocyte density, and secondary focal segmental glomerulosclerosis (FSGS). However, how lipid overload, particularly palmitic acid (PA), whose plasma levels are frequently elevated in obesity, injures podocytes remains incompletely understood. Human podocytes were exposed to PA (100 M for 24 hours), and we assessed lipid accumulation, WT1 expression and promoter activity, TGF-{beta}1 signaling, and cell-cycle regulators. PA induced lipid droplet accumulation and increased WT1 expression in podocytes. Concurrently, PA treated podocytes showed cytoskeletal aberrations, loss of podocyte structural genes (podocin, nephrin and synaptopodin) and TGF-{beta}1/Smad2 axis causes upregulation of fibronectin, collagen, and -SMA. Similarly, mice fed a high-fat diet (HFD) for 16 weeks exhibited TGF- {beta}1 activation in podocyte enriched glomeruli together with glomerulosclerosis, impaired kidney function, and podocyte loss. In both models, Cyclin D1, Cyclin B1, CDK4, p53, and p21 were increased. Notably, ~30% of PA-treated podocytes were binucleated, yet podocyte number did not increase. Lipotoxic stress was associated with concurrent induction of WT1 and TGF-{beta}1, loss of the podocyte phenotype, and abortive cell-cycle re-entry accompanied by binucleation and podocyte loss. These findings point to a WT1-TGF-{beta}1-cell-cycle axis as a potential contributor to ORG and a candidate therapeutic target. Whether WT1 directly regulates TGF-{beta}1 remains to be determined.